Purpose: To review the methodologies used to assess muscle co-contraction (MCo) with surface electromyography (sEMG) during gait in people with neurological impairment. Methods: The Scopus (1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013), Web of Science (1970Science ( -2013, PubMed (1948PubMed ( -2013 and B-on (1999-2013) databases were searched. Articles were included when sEMG was used to assess MCo during gait in people with impairment due to central nervous system disorders (CNS). Results: Nineteen articles met the inclusion criteria and most studied people with cerebral palsy and stroke. No consensus was identified for gait assessment protocols (surfaces, speed, distance), sEMG acquisition (electrodes position), analysis of sEMG data (filters, normalisation techniques) and quantification of MCo (agonist-antagonist linear envelopes overlapping or agonist-antagonist overlapping periods of muscles activity, onset delimited). Conclusion: Given the wide range of methodologies employed, it is not possible to recommend the most appropriate for assessing MCo. Researchers should adopt recognized standards in future work. This is needed before consensus about the role that MCo plays in gait impairment in neurological diseases and its potential as a target for gait rehabilitation can be determined.
Introduction
Gait patterns are usually impaired in people with dysfunction of the Central Nervous System (CNS), such as stroke (Knutsson and Richards, 1979) , traumatic brain injury (Chow et al., 2012) , cerebral palsy (Hesse et al., 2000) or Parkinson's disease (Dietz et al., 1981) . Walking is a very complex function involving multiple interactions between muscle groups which can be adapted to enable walking at different speeds or on different surfaces (Winter, 2009 ). Neurological impairments can generate many deviations in muscle activity and gait kinematics from those seen in healthy individuals and reduce the ability to adapt gait appropriately to different environmental conditions. Gait patterns in people with neurological impairment have been characterized by abnormal muscle co-contraction, especially when postural stability is challenged (Lamontagne et al., 2000) .
Muscle Co-contraction (MCo) is the mechanism that regulates simultaneous activity of agonist and antagonist muscles crossing the same joint (Busse et al. 2005) . There is no consensus about the role that MCo plays in the various stages of recovery after CNS disease. However as MCo has been demonstrated to be important for providing adequate joint stability, movement accuracy and energy efficiency (Higginson et al. 2006 ) and adapting to environmental demands (Darainy and Ostry, 2008) , its importance in neurological recovery is worthy of consideration.
Accurate determination of the impact of neurological impairment on MCo during gait requires robust measurement techniques which take careful consideration of the environmental conditions under which gait is assessed (Den Otter et al. 2004) . For instance, walking on a ground surface instead of on a treadmill, walking at different speeds and for longer distances/duration would increase MCo recruitment and the variability between subjects (Parvataneni et al. 2009; Knarr et al. 2012 ). The first research question addressed by this review therefore is:
What are the main characteristics of the gait assessment protocols particularly, the surfaces where people walked, the speed, distance and time spent walking? Which muscles have been assessed? All measurement techniques, including sEMG, are liable to measurement error which can reduce validity and reliability and confound interpretation of the findings. MCo assessment during functional movements, such as walking, requires the analysis of the relative variations in agonist and antagonist contraction over time using surface electromyography (sEMG) equipment (Fonseca et al. 2001; Fonseca et al. 2004) . Standards have been developed for reporting sEMG signals in different processing stages, such as the signal acquisition (Surface Electromyography for the Non-Invasive Assessment Muscles (SENIAM) guidelines), and analogue and digital analysis (International Society of Electrophysiology and Kinesiology (ISEK) guidelines) (Merletti 1999) , but the implementation of these is variable. Despite these guidelines, controversies remain about the most appropriate techniques of sEMG signal analysis; (e.g., selection of normalisation technique) leading to inconsistencies across studies (Burden et al., 2003) . Therefore, the second research question this review sought to answer is:
What are the main steps in the acquisition and analysis of the sEMG signals and which parameters have been considered when quantifying MCo?
A single definition of MCo would also be facilitate interpretation of MCo outcomes during walking. However MCo has been defined in different ways: the magnitude; the time; or a ratio between the magnitude and time of simultaneous activation of opposite muscles (Fonseca et al. 2001 ). As a result of different definitions, different formulas or computational approaches to quantify MCo have been employed (Fonseca et al. 2001) . All these methodological differences limit the comparison of data across studies and the understanding of the mechanisms of MCo. The third research question for this review is therefore:
Which formulas or computational approaches have been used to quantify MCo?
This paper addresses the need to systematically review, synthesize and critique the methodologies used in this field, contributing to a better understanding of the mechanisms underpinning MCo and of its role in gait in people with CNS disease.
Methods

Variable of interest
The variable of interest in this study was MCo during gait, presented as the time and/or the magnitude of simultaneous contraction between opposite muscles (Fonseca et al. 2001 ).
Search strategy
The literature search was performed from date of inception until end of November 2012 on the following databases: Scopus (1995 Scopus ( -2013 , Web of Science (1970 -2013 ), PubMed (1948 -2013 and B-on (1999-2013) . B-on includes the Academic Search Complete (EBSCO), Annual Reviews, Elsevier-Science Direct, Nature, Springer Link (Springer/Kluwer), Taylor &Francis and Wiley Online Library (Wiley). Weekly updates were performed until October 2013.
The following search term (free text words) combinations were used in PubMed database: co-contraction AND gait, co-contraction AND locomotion, co-contraction AND Walking; co-activation AND gait; co-activation AND locomotion, co-activation AND walking. Search strategies in the other databases were derived from PubMed. The search terms were limited to titles and abstracts. The reference lists of all studies were also scanned to identify other potentially eligible articles.
The study was conducted using the systematic review method proposed by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) (Moher et al. 2009 ), as shown in Fig. 1 .
Full papers, written in English or Portuguese that met the following criteria were included if they: (i) studied gait impairment due to neurological diseases, such as stroke, Parkinsoń s disease, cerebral palsy, traumatic brain injury and other CNS dysfunctions; and ii) analysed MCo during gait of the lower or upper limb or trunk using sEMG. All articles were independently reviewed by two reviewers for relevance and quality using PRISMA (Moher et al. 2009 ). Any discrepancies were resolved through discussion.
Results
Fig. 1 portrays the number of articles identified, the numbers and reasons for exclusion and the total number of studies included in the final review A descriptive analysis of the methodologies (study design; sample; data collection protocol; sEMG data acquisition and analysis and quantification of MCo) of the included studies is presented in Table 1 .
Study design and sample
Most studies included in this review had observational designs, with the exception of two experimental studies (Hesse et al. 2000; Massaad et al. 2010) . The observational studies assessed MCo during gait with no intervention or program. From those studies, only one was longitudinal (Den Otter et al. 2006) , with data collection over five time points. The experimental study used non-randomized control groups and assessed gait before and after an intervention (Concato 2004) . With the exception of six articles (Hesse et al. 1999; Damiano et al. 2000; Hesse et al. 2000; Detrembleur et al. 2003; Keefer et al. 2004; Massaad et al. 2010 ) all others included a group of healthy participants to provide normative comparison of MCo. MCo during gait was studied in several neurological conditions including stroke (Knutsson and Richards, 1979; Hesse et al. 1999; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Den Otter et al. 2006; Den Otter et al. 2007; Massaad et al. 2010; Chow et al. 2012) , cerebral palsy (Leonard et al. 1991; Unnithan et al. 1996; Damiano et al. 2000; Hesse et al. 2000; Keefer et al. 2004; Wakeling et al. 2007; Prosser et al. 2010; Assumpção et al. 2011) , multiple sclerosis and cerebral tumor (Knutsson and Richards, 1979; Dietz et al. 1981 ), Parkinson's disease (Dietz et al. 1981; Arias et al. 2012) , traumatic brain injury (TBI) (Chow et al. 2012 ) and finally, myelopathy, sclerosis, amyotrophy and meningitis (Dietz et al. 1981) .
Sample sizes varied from 5 (Leonard et al. 1991) to 30 participants (Lamontagne et al. 2000) . In some studies, age (Knutsson and Richards, 1979; Dietz et al. 1981; Den Otter et al. 2006; Den Otter et al. 2007; Prosser et al. 2010 ) and gender (Knutsson and Richards, 1979; Lamontagne et al. 2000; Lamontagne et al. 2002; Prosser et al. 2010 ) criteria were not well-matched between the group of people with CNS disorders and the healthy controls. Anthropometric data, including height and weight, were described in seven studies (Unnithan et al. 1996; Damiano et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Prosser et al. 2010; Assumpção et al. 2011) . The others described either weight (Hesse et al. 2000) or height (Massaad et al. 2010; Arias et al. 2012) .
3.2. Research Question 1: What are the main characteristics of the gait assessment protocols particularly, the surfaces where people walked, the speed, distance and time spent walking? Which muscles were assessed?
Different surfaces were used to assess gait in the included studies. In some studies, a walkway (usually a corridor on the floor) was used (Knutsson and Richards, 1979; Damiano et al. 2000; Hesse et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Keefer et al. 2004; Wakeling et al. 2007; Assumpção et al. 2011; Arias et al. 2012; Chow et al. 2012) , whereas in others participants walked on a treadmill (Dietz et al. 1981; Leonard et al. 1991; Unnithan et al. 1996; Den Otter et al. 2006; Den Otter et al. 2007; Massaad et al. 2010; Prosser et al. 2010) . Gait performance on a treadmill was compared to gait performance on the ground in one study (Hesse et al. 1999) .
A wide variety of instructions were given to participants regarding the speed they should walk. A number of studies used a free/ normal/self-selected speed (Knutsson and Richards, 1979; Dietz et al. 1981; Leonard et al. 1991; Hesse et al. 1999; Damiano et al. 2000; Hesse et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Den Otter et al. 2007; Wakeling et al. 2007; Massaad et al. 2010; Prosser et al. 2010; Assumpção et al. 2011; Chow et al. 2012) . In three studies subjects were instructed to walk as quickly as possible (Unnithan et al. 1996; Hesse et al. 1999; Den Otter et al. 2006 ) but only in two of these studies, average gait speeds were reported: 0.27 m per second (Hesse et al. 1999) ; an average of 3 km per hour achieved when asking patients to walk at 90% of maximum speed during 2 min (Unnithan et al. 1996) . Keefer et al. (2004) asked patients to perform three 5-min walking trials at 0.67, 0.89 and 1.12 m per second, controlled by a treadmill setting. One study (Arias et al. 2012 ) assessed walking in three different conditions: subjects were first instructed to walk at their preferred speed, then at fast speed and finally, to match their steps with a pulsing rhythm provided by a metronome (Arias et al. 2012) . Moreover, in most studies (Knutsson and Richards, 1979; Dietz et al. 1981; Leonard et al. 1991; Hesse et al. 1999; Damiano et al. 2000; Hesse et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Wakeling et al. 2007; Massaad et al. 2010; Prosser et al. 2010; Assumpção et al. 2011; Arias et al. 2012; Chow et al. 2012 ) impaired and healthy participants were given the same instructions but in 3 other studies (Lamontagne et al. 2000; Lamontagne et al. 2002; Chow et al. 2012 ) the healthy participants were asked to walk ''very slowly'' in an attempt to control for the effect of gait speed on MCo patterns. Dietz et al. (1981) Subjects with spastic or rigidity gait (n = 20)
Walking on a treadmill Not described (1) Envelope: rectification low pass filter at 50 Hz 
Children with cerebral palsy (n = 9)
Walking on a treadmill with total support in treadmill bars, supported around waist, totally unaided The walking distance or the time spent walking also varied: four studies (Lamontagne et al. 2000; Hesse et al. 2001; Lamontagne et al. 2002; Detrembleur et al. 2003 ) asked participants to walk 10 m and Knutsson and Richards (1979) and Chow et al. (2012) used 5 m. Distances longer than 10 m were also used by Hesse et al. (1999) , Damiano et al. (2000) and Arias et al. (2012) ; whilst the time spent walking was the criterion used to define the protocol in the other studies, ranging from 40 s (at a maximum speed) (Keefer et al. 2004 ) to 30 min (at a comfortable speed) (Massaad et al. 2010 ).
MCo was acquired from different muscles during gait performance. Four studies assessed thigh muscles (Damiano et al. 2000; Keefer et al. 2004; Prosser et al. 2010; Assumpção et al. 2011) , five studies assessed only shank muscles (Dietz et al. 1981; Lamontagne et al. 2000; Lamontagne et al. 2002; Arias et al. 2012; Chow et al. 2012 ) whilst the others assessed muscles of the entire lower limb. Only one study assessed MCo from trunk muscles and (Prosser et al. 2010 ) there were no articles assessing MCo of the upper limb or any other body structures during gait.
Research Question 2:
What were the main steps in the acquisition and analysis of the sEMG signals and which parameters were considered when quantifying MCo? Data acquisition was inconsistent across studies. Only five studies followed the SENIAM recommendations for both electrode placement and skin preparation (Detrembleur et al. 2003; Den Otter et al. 2006; Den Otter et al. 2007; Prosser et al. 2010; Assumpção et al. 2011) . Six studies did not describe electrode position (Dietz et al. 1981; Leonard et al. 1991; Damiano et al. 2000; Hesse et al. 2000; Wakeling et al. 2007; Massaad et al. 2010) ; only one of these described how the skin was prepared (Damiano et al. 2000) .
The analogue and digital processing of the sEMG signal was performed differently across studies. Analogue processing usually involves two main steps: pre-amplification and application of filters. However, two older studies (Knutsson and Richards, 1979; Dietz et al. 1981) included in this review, used analogue techniques to construct the linear envelope (LE) of the signal.
Several amplifiers were employed, with different values of common mode rejection ratio and input impedance, assuming values from 50 dB (Chow et al. 2012 ) to 110 dB (Assumpção et al. 2011 ) and values from 10 KO (Unnithan et al. 1996; Lamontagne et al. 2000; Lamontagne et al. 2002) to 31 MO (Chow et al. 2012) respectively. Analogue filter characteristics were also different, assuming high-pass cut-off values of 10 Hz (Unnithan et al. 1996) (Leonard et al. 1991) or 4000 Hz (Keefer et al. 2004 ). Digital filters employed in studies also had different low and high cut-off frequencies. Low cut-off frequencies ranged from 300 Hz (Hesse et al. 1999; Detrembleur et al. 2003; Massaad et al. 2010 ) to 500 Hz (Assumpção et al. 2011; Chow et al. 2012) and high cut-off frequencies ranged from 10 Hz (Hesse et al. 1999; Lamontagne et al. 2000; Lamontagne et al. 2002; Den Otter et al. 2006; Den Otter et al. 2007; Assumpção et al. 2011; Chow et al. 2012 ) and 25 Hz (Detrembleur et al. 2003; Massaad et al. 2010) .
A LE was digitally constructed in the majority of studies, however a wide range of smoothing parameters (low-pass filters) were used: 3 Hz ( Normalization is a procedure of referencing EMG data to a standard value, allowing data comparison between muscles, across time and between subjects (Soderberg and Knutson, 2000; Burden et al. 2003) . EMG signals can be normalized using temporal and amplitude parameters. Different temporal parameters were used in the included studies: each 5% of gait cycle duration (Knutsson and Richards, 1979; Dietz et al. 1981 ); 100% of step cycle duration (Leonard et al. 1991) ; mean cycle duration and 100% of gait cycle duration (Damiano et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Keefer et al. 2004; Den Otter et al. 2006; Den Otter et al. 2007 ). Amplitude parameters were also different across the studies: mean amplitude (Assumpção et al. 2011; Chow et al. 2012) or peak value (Knutsson and Richards, 1979; Dietz et al. 1981; Unnithan et al. 1996; Arias et al. 2012) in each gait cycle; mean amplitude of a total of three gait cycles (Keefer et al. 2004) ; and, mean value or largest value of maximal voluntary contraction (MVC) (Knutsson and Richards, 1979; Dietz et al. 1981; Unnithan et al. 1996) . Lamontagne et al. (2000 Lamontagne et al. ( , 2002 questioned the value of normalizing data, claiming that selection of a single maximum value could be affected by electrical noise and that the muscle activity recorded during maximal voluntary strength could be very different in healthy subjects and those with stroke. Therefore, these authors did not apply any amplitude normalization, quantifying MCo using absolute sEMG values.
Several intensity and timing parameters were considered in the analysis of sEMG during gait. The following intensity parameters were used to analyse the sEMG signal: the peak amplitude in each gait cycle (Knutsson and Richards, 1979; Dietz et al. 1981; Lamontagne et al. 2000; Lamontagne et al. 2002) , the area of the envelope (Unnithan et al. 1996; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Keefer et al. 2004; Assumpção et al. 2011; Arias et al. 2012; Chow et al. 2012) or a mean value of it (Damiano et al. 2000) . Duration of muscle activity depends on accurate determination of the onset and offset of muscle contraction. Muscle contraction onset is a parameter used to mark the beginning of muscle activity and it was determined by using various computerized methods (Unnithan et al. 1996; Hesse et al. 2000; Prosser et al. 2010; Chow et al. 2012) or by visual inspection of the sEMG signal (Detrembleur et al. 2003) . Within the computerized methods, Unnithan et al. (1996) determined onset when sEMG assume values between 5% and 10% above the maximum voluntary contraction value; Hesse et al. (2000) identified onset as any significant burst which achieved at least 10% of a maximum sEMG recorded and lasted at least 5% of a cycle duration; Prosser et al. (2010) determined onset periods using a Teager-Kaiser energy operator, an automatic filtering and de-noising approach; Chow et al. (2012) determined onset when the sEMG signal exceeded three standard deviations of the mean. Visual inspection, to define muscle onsets, was performed in one study by two independent raters observing graphs of previously averaged and normalized sEMG data, (Hesse et al. 1999) . A consensus of opinion between both raters determined the definition of muscle temporal patterns. No information was provided about the determination of offsets in any of the included papers.
Research Question 3: Which formulas or computational approaches have been used to quantify MCo?
MCo was quantified using different formulas or computational approaches. Two different approaches were used to quantify the temporal MCo: i) the time of overlap between LE of two opposite muscles (Unnithan et al. 1996; Damiano et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Assumpção et al. 2011; Chow et al. 2012) and ii) the time of overlap between activity periods (onset delimited) of opposite muscles (Knutsson and Richards, 1979; Dietz et al. 1981; Leonard et al. 1991; Hesse et al. 1999; Detrembleur et al. 2003; Den Otter et al. 2006; Massaad et al. 2010; Prosser et al. 2010) .
To quantify the magnitude of MCo, Hesse et al. (2000) , Keefer et al. (2004) and Arias et al. (2012) divided the common area of the LE of antagonist muscles by the sum of the areas of those muscles. Unnithan et al. (1996) divided the common area of LE between two muscles by the number of data points and Assumpção et al. (2011) and Damiano et al. (2000) calculated the difference between the minimum and maximum values of opposite muscles in each point of the gait cycle. The amount of MCo was also measured using (i) the mean value of the area of overlap (Damiano et al. 2000) , (ii) a correlation between the spectra of two opposite muscles (Wakeling et al. 2007 ), (iii) a quantification of the area of overlap between opposite muscles (Assumpção et al. 2011) or (iv) dividing this area by the overlap duration (Chow et al. 2012 ).
Discussion
This systematic review explored the methodologies used to assess MCo during gait in people with CNS disorders, that in most cases were stroke and cerebral palsy (Knutsson and Richards, 1979; Dietz et al. 1981; Leonard et al. 1991; Hesse et al. 1999; Damiano et al. 2000; Hesse et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Keefer et al. 2004; Den Otter et al. 2006; Den Otter et al. 2007; Wakeling et al. 2007; Massaad et al. 2010; Prosser et al. 2010; Assumpção et al. 2011; Chow et al. 2012) . Given the considerable variability in the methods used to assess gait, analyse sEMG and quantify MCo, no recommendations can be made at this time about the most appropriate methodologies to assess MCo during gait in people with CNS disorders.
Several differences were found in the gait protocols of the included studies, including the walking speed, ground surface and duration or the distance that people walked. Walking speed is known to influence muscle activity in both healthy people and those with impairment (Hesse et al. 2001 ). In the majority of studies, participants were instructed to walk at their self-selected speed (Knutsson and Richards, 1979; Dietz et al. 1981; Leonard et al. 1991; Hesse et al. 1999; Damiano et al. 2000; Hesse et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Wakeling et al. 2007; Massaad et al. 2010; Prosser et al. 2010; Assumpção et al. 2011; Chow et al. 2012 ). However, as the self-selected speed of healthy subjects is obviously different from those with CNS disorders, some authors (Lamontagne et al. 2000; Lamontagne et al. 2002; Chow et al. 2012) tried to control for the influence of speed on gait pattern and match data capture conditions by instructing controls to walk at a very slow speed. However, subjects are walking under unusual circumstances which may increase postural instability (Den Otter et al. 2004 ) and may cause different muscle activity bursts (Lingling et al. 2010 ). This may not therefore be the most appropriate methodology for defining speed during gait. Self-selected gait speed for both healthy people and people with CNS disorders might be the most accurate methodology for comparing sEMG data.
Ground surface is also known to influence muscle activity. In subjects with stroke, there is a tendency to increase cadence and to induce muscle activity modifications (e.g., earlier muscle contraction onset) during treadmill walking, compared with walking on the ground (Harris-Love et al., 2004) . This makes comparison between the results obtained in ground walking (Knutsson and Richards, 1979; Dietz et al., 1981; Damiano et al., 2000; Hesse et al., 2000; Lamontagne et al., 2000; Lamontagne et al., 2002 (Dietz et al., 1981; Leonard et al., 1991; Unnithan et al., 1996; Den Otter et al., 2006; Massaad et al., 2010; Prosser et al., 2010) . There are, however, practical reasons why the different surfaces may have been selected for use with people with CNS disorders. Treadmill walking offers a more restricted space, protective bars and better monitoring conditions to enhance safety in people with poor balance (Laufer et al., 2001) . However, studies using ground walking are more reflective of everyday life and may be easier and cheaper to conduct. A validation study exploring what incline grade a treadmill should be at to more closely replicate walking on a ground surface (Laufer et al., 2001; Mason et al., 2013) would be a useful future step.
Subjects with CNS disorders tend to increase their MCo magnitude to be able to walk longer or further, resulting in inefficient MCo strategies and abnormal walking patterns and potentially contributing to fatigue and muscle pain (Dean et al., 2001; Brunner and Romkes, 2008) . Recommendations to the most appropriate walking distance or time for use in sEMG studies are therefore needed.
Despite publication of the SENIAM guidelines for sensor placement procedures in 1996 (Hermens et al., 2000) and of ISEK guidelines for reporting sEMG data acquisition (Merletti, 1999) and signal analysis in 1999, many studies in this review did not adhere to the recommendations nor offer justification for their lack of adherence. The fulfillment of these guidelines is determinant for the analysis of MCo, as it affects the characteristics of the sEMG signal recorded from opposite muscles (Fonseca et al., 2001) .
In terms of sensor placement, the first study from this review to follow these guidelines was from 2003 (Detrembleur et al., 2003) but a further five later studies (Keefer et al., 2004; Wakeling et al., 2007; Massaad et al., 2010; Arias et al., 2012; Chow et al., 2012) did not follow the SENIAM acquisition recommendations.
In terms of signal processing analysis, the use of bandwidth amplifier filters within the range of 5-500 Hz and the use of low pass filters at 5 or 6 Hz to smooth the full-wave rectified signal, constructing a LE (Merletti, 1999) were important ISEK recommendations. However, most studies in this review used amplifier filters with characteristics different from those recommended (Merletti, 1999) , high-pass cut-offs at 20 Hz (Lamontagne et al., 2000; Lamontagne et al., 2002; Keefer et al., 2004; Den Otter et al., 2006; Den Otter et al., 2007; Prosser et al., 2010) and low-pass cut-offs varied from 4000 Hz (Keefer et al., 2004) to 450 Hz (Prosser et al., 2010) Only Assumpção et al. (2011) used a 6 Hz low-pass filter to construct a LE, following the recommendations (Merletti, 1999) . Differences in sEMG data acquisition and analysis of the included studies hinder the comparison of results across studies, therefore future research should strictly adhere to the SENIAM and ISEK recommendations or be able to offer a scientific justification for non-adherence.
There are no guidelines for the most adequate procedures for normalizing sEMG signal during gait (Burden et al., 2003) . Temporal normalization was the most commonly used procedure in the included studies (Dietz et al., 1981; Hesse et al., 2000; Lamontagne et al., 2000; Detrembleur et al., 2003; Massaad et al., 2010; Assumpção et al., 2011) . Temporal normalization involves defining a reference time period (e.g., each 5% of gait cycle) to enable comparison between individuals, across muscles or between trials. The use of temporal normalization alone, in the absence of any other method of normalization, has been criticized because it ignores the relative amplitude of the signal, potentially resulting in signals of inappropriate amplitudes being considered as normal (Bogey et al., 1992) .
Determining the most appropriate method for normalizing sEMG amplitude is controversial. The aim of this procedure is to express the activity between muscles, across time and between individuals in relation to a reference value obtained during standard and reproducible conditions (Burden and Bartlett, 1999) .
Three studies recorded reference values during maximum isometric voluntary contraction (MVC) (Dietz et al., 1981; Unnithan et al., 1996; Damiano et al., 2000) ; however, in patients with neurological conditions, this may not represent the maximum activation capacity of the muscle, resulting in increased inter-subject variation (Burden and Bartlett, 1999) . The mean ensemble value (mean value reached within a period) was used in three other studies (Keefer et al., 2004; Assumpção et al., 2011; Chow et al., 2012) . Mean ensemble value and peak ensemble value (maximum value reached within a period), have both been considered feasible methods for normalizing data from neurological patients (Yang and Winter, 1984) . These methods consist of dividing each sEMG data point by the mean or the peak value recorded from the same sEMG portion of data (Burden et al., 2003) . These are more reliable methods as they have the capacity to reduce inter-subject variability (Yang and Winter, 1984) .
The area of overlap between the LE of opposite muscles was used in eight studies (Damiano et al., 2000; Hesse et al., 2000; Lamontagne et al., 2000; Lamontagne et al., 2002; Keefer et al., 2004; Assumpção et al., 2011; Arias et al., 2012; Chow et al., 2012 ) to achieve a value of time or intensity of MCo during gait. The mean value of overlap could also be an important parameter for quantifying MCo (Damiano et al., 2000) . An index based on the area of overlap between the LE of two opposing muscles in a specific time window was used in two studies (Unnithan et al., 1996; Chow et al., 2012) . A LE is a linear distribution of amplitudes at each gait cycle interval proposed (Shiavi et al., 1998) as a good method for studying synergy patterns during gait. However, various factors in the EMG measurement process might influence the establishment of representative LÉ s profiles, such as electrode location, thickness of subcutaneous tissues or the system used to detect the signal (Farina et al., 2004) and therefore using amplitude parameters for comparative purposes has been criticised (Farina et al., 2004) . LE repeatability can be improved by precision in electrode placement and skin preparation and by following recommendations for sEMG signal analysis (Arsenault et al., 1986; Shiavi et al., 1998) : between six and ten strides, depending on the variability of each muscle assessed and an envelope filter with a cut-off frequency 8.9 Hz are recommended. However some authors (Morey-Klapsing et al., 2004; Raez et al., 2006) remain critical of the use of amplitude parameters for inter-subject comparison.
An alternative method used to quantify MCo in the studies in this review, was the estimation of time during which opposing muscles are active (Knutsson and Richards, 1979; Dietz et al., 1981; Shiavi et al., 1998; Detrembleur et al., 2003; Den Otter et al., 2006; Massaad et al., 2010; Prosser et al., 2010) . This method depends on the accuracy of the process used to detect muscle contraction onset (Kerem et al., 2010) . At least three different processes have been used: visual inspection, threshold computation and automated algorithms (Kerem et al., 2010) . Variability within the automatic methods has also been found as both simple (intensity) (Unnithan et al., 1996; Chow et al., 2012) and double (time and intensity) (Hesse et al., 2000) threshold methods have been used. Double-threshold methods have some potential to eliminate false positives or delayed onset detection, however the establishment of thresholds were inconsistent across studies (Staude et al., 2001) . This variability hinders the comparison of temporal MCo patterns and therefore a consensus on temporal automatic methods is needed, improving the sensitivity of the thresholds to the signal parameters.
The variability found in the methods used to estimate MCo and the lack of reliability of sEMG intensity parameters makes it difficult to compare MCo patterns between studies. Further research should therefore follow guidelines for sEMG data acquisition and analysis and reach a consensus on the temporal MCo estimation.
Limitations
This review was limited to studies investigating gait in people with neurological impairment in order to minimize methodological variability which would occur due to the specific requirements of different populations (Burden et al., 2003) . However, further reviews on MCo during gait in other disorders such as osteoarticular (Heiden et al., 2009) , ligament (Chmielewski et al., 2005) or developmental disorders (Gontijo et al., 2008) are still required. Such reviews may facilitate the generation of methodological consensus across a range of conditions. In addition, only articles written in Portuguese and English were included in this systematic review narrowing the number of eligible articles.
Conclusion
A systematic review was undertaken to review the literature concerning the methodologies used for measuring MCo during gait in people with neurological impairment due to CNS disorders.
It was not possible to make recommendations about the most appropriate methodologies for assessing MCo during gait in people with CNS disorders because of the considerable range of gait protocols and methods for the acquisition, analysis of sEMG and quantification of MCo. The area of overlap between the LE of opposite muscles and also the estimation of onset-delimited temporal MCo offer potential as methods for quantifying MCo. However, for improving repeatability of MCo outcomes methodological criteria for sEMG data collection must be fulfilled and the automatic methods for determining double-thresholds validated.
Given that MCo is being considered as a potential parameter to target in gait rehabilitation (Den Otter et al., 2006) more robust standardized methods of evaluation and a rigorous adherence to SENIAM and ISEK guidelines are required.
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